0001437749-23-028277.txt : 20231016 0001437749-23-028277.hdr.sgml : 20231016 20231016160020 ACCESSION NUMBER: 0001437749-23-028277 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231006 FILED AS OF DATE: 20231016 DATE AS OF CHANGE: 20231016 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rees Heather CENTRAL INDEX KEY: 0001997454 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35610 FILM NUMBER: 231327342 MAIL ADDRESS: STREET 1: C/O ATOSSA THERAPEUTICS, INC. STREET 2: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001488039 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264753208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206.588.0256 MAIL ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 FORMER COMPANY: FORMER CONFORMED NAME: ATOSSA GENETICS INC DATE OF NAME CHANGE: 20100325 3 1 rdgdoc.xml FORM 3 X0206 3 2023-10-06 0 0001488039 ATOSSA THERAPEUTICS, INC. ATOS 0001997454 Rees Heather C/O ATOSSA THERAPEUTICS, INC. 107 SPRING STREET SEATTLE WA 98104 1 SVP, Finance and Accounting Stock Option (Right to Buy) 1.4800 2030-04-09 Common Stock 32500 D Stock Option (Right to Buy) 3.1800 2030-07-03 Common Stock 23500 D Stock Option (Right to Buy) 2.9000 2031-05-14 Common Stock 129700 D Stock Option (Right to Buy) 3.1800 2031-08-11 Common Stock 100000 D Stock Option (Right to Buy) 0.9300 2032-05-13 Common Stock 150000 D Stock Option (Right to Buy) 0.9200 2033-06-12 Common Stock 226000 D The options are fully vested. The options vest in equal quarterly installments over a period of two years from the grant date, May 13, 2022, subject to the Reporting Person's continued service to Issuer through each vesting date. The options vest in equal quarterly installments over a period of two years from the grant date, June 12, 2023, subject to the Reporting Person's continued service to Issuer through each vesting date. Exhibit 24 - Power of Attorney /s/ Heather Rees 2023-10-16 EX-24 2 atos_ex24.htm ex_581192.htm

Exhibit 24

 

POWER OF ATTORNEY

 

 

The undersigned hereby constitutes and appoints each of Aaron K. Briggs and Ryan A. Murr of Gibson, Dunn & Crutcher LLP, signing singly, as the undersigned’s true and lawful attorney-in-fact to:

 

1.

execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Atossa Therapeutics, Inc. (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

 

2.

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Forms 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such form with the U.S. Securities and Exchange Commission and any stock exchange or similar authority; and

 

3.

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. This Power of Attorney revokes all previous powers of attorney with respect to the subject matter of this Power of Attorney.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 12th day of October 2023.

 

 

/s/ Heather Rees                   

Name: Heather Rees